JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schoepke, H. G.
Right arrow Articles by Shideman, F. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schoepke, H. G.
Right arrow Articles by Shideman, F. E.
Journal of Pharmacology And Experimental Therapeutics, Vol. 133, Issue 2, 171-179, 1961
Copyright © 1961 by American Society for Pharmacology and Experimental Therapeutics


CARDIAC EFFECTS OF 4-METHYL-2-AMINOPYRIDINE AND SOME OF ITS ISOMERS

Hollis G. Schoepke 1 and F. E. Shideman 1

1 Department of Pharmacology and Toxicology and The Cardiopulmonary Research Laboratory, University of Wisconsin, Madison, Wisconsin

The effects of 4-methyl - 2 - aminopyridine (4M2AP) and its 3-methyl-, 5-methyl- and 6-methyl-isomers were determined on isolated auricles (atria) and papillary muscles of the cat and heart-lung preparations of the dog. All compounds exhibited positive inotropic and chronotropic activities which were most marked in the case of 4M2AP. Effective doses of 4M2AP restored competence in the failing heart-lung preparation of the dog for periods of 1 hour or longer. No evidence of the development of any refractoriness to the cardiostimulant actions of these pyridine derivatives could be demonstrated. Their effects on papillary muscles or auricles were not significantly altered by atropine or ganglionic blocking agents (nicotine, hexamethonium, tetraethylammonium, d-tubocurarine).

Experiments in which the responsiveness of the papillary muscle to 4M2AP, TMA and amphetamine in various orders of exposure and concentration was studied suggest that these agents act at a common site but differ in terms of their affinities for receptors at this site.

Administration of reserpine to cats markedly reduced the concentration of their myocardial catecholamines and abolished the responsiveness of papillary muscles and auricles to 4M2AP and its isomers. 1-(3,4-I)ichlorophenyl)-2-isopropyl-aminoethanol hydrochloride (DC1) blocked the cardiostimulant effects of these pyridine derivatives on all the cardiac preparations studied. Trimethyl-(2-(2,6-xylyloxy)-propyl) ammonium chloride (SKF-6890A), in doses which failed to alter the cardiostimulant responses to epinephrine, also blocked the positive inotropic effects of 4M2AP and its isomers on the papillary muscle and the positive inotropic and chronotropic action of these compounds on the auricles. These findings suggest that 4M2AP and its isomers cause the release of catecholamines from either sympathetic nerve endings and/or other storage Sites.

Submitted on February 6, 1961







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1961 by the American Society for Pharmacology and Experimental Therapeutics.